Clinical Trial Update: Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating progesterone for managing preterm premature rupture of membranes (PPROM) across Phase 1 and Phase 2; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Rupture of Membranes
• Preterm Birth Complications

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: Stanford University | Conditions: Pregnancy Complications | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-17